The vaccine, among the first to be tested in humans in the United States, was found to produce protective antibodies in a small group of healthy volunteers.
Under the deal, Catalent will provide manufacturing services for an initial 100 million doses starting in the third quarter at its facility in Bloomington, Indiana.
It will also provide other packaging and labeling, storage and distribution services at its facilities in Philadelphia, Pennsylvania to support Moderna's late-stage vaccine trial, which is expected to begin in July.
Drugmakers including Johnson & Johnson and AstraZeneca Plc have also signed agreements to boost manufacturing capacity for their experimental vaccines even before having adequate evidence of their efficacy.
There are no approved treatments or vaccines for COVID-19 and experts have cautioned that a safe and effective vaccine may take at least 12 to 18 months from the start of development.
Vaccines by other drugmakers including Johnson & Johnson, Sanofi SANY.PA and AstraZeneca Plc are in various stages of development and about a dozen vaccines are currently being tested in humans.
Both Moderna and Catalent are also in talks for making hundreds of millions of additional doses.
Aware of her elements, Neha writes the best articles across industries including electronics & semiconductors, automotive & transportation and food & beverages. Being from the finance background she has the ability to understand the dynamics of every industry and analyze the news updates to form insightful articles. Neha is an energetic person interested in music, travel, and entertainment. Since past 5 years, she written extensively on sectors like technology, finance and healthcare.
Smarter Decisions with Smart News
Smart Market News is committed to getting its readers the latest updates and insights on industries that help in making “smarter” business decisions. With insights and inputs from corporate decision makers, we bring you the stories of adopting innovative solutions and strategies that have been changing the world. Our editorial insights on products, solutions, companies, and adoption of best practices not only help in understanding the markets better, but also prove to be a complete package for your information needs.